From July 5, 2023 to July 11, 2023, the company has repurchased 1,121,900 shares, representing 0.25% for CNY 30.1 million. With this, the company has completed the repurchase of 1,121,900 shares, representing 0.25% for CNY 30.1 million under the buyback announced on July 5, 2023.
Guangzhou Wondfo Biotech Co.,Ltd
Equities
300482
CNE100002102
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.77 CNY | -3.00% | -2.84% | -4.64% |
May. 06 | Wondfo Biotech's Unit Gets Emergency Use Authorization from US FDA | MT |
Apr. 21 | Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.64% | 1.87B | |
-4.32% | 12.32B | |
-4.76% | 8.1B | |
+8.27% | 5.87B | |
+28.39% | 5.52B | |
-6.28% | 4.29B | |
-52.84% | 3.16B | |
+12.93% | 2.72B | |
-2.57% | 2.37B | |
+28.84% | 2.23B |
- Stock Market
- Equities
- 300482 Stock
- News Guangzhou Wondfo Biotech Co.,Ltd
- Tranche Update on Guangzhou Wondfo Biotech Co.,Ltd's Equity Buyback Plan announced on July 5, 2023.